AbbVie Exceeds Q2 Expectations, Lowers Full-Year EPS Guidance Due to M&A

AbbVie reported second-quarter earnings that surpassed analyst expectations, though the company subsequently lowered its full-year earnings per share guidance, citing the impact of mergers and acquisitions.